Posted by Dale Buss on October 1, 2012 09:02 AM
3M plans to acquire ceramics maker Ceradyne.
Amazon comes under fire for offering Nazi death-camp puzzle.
AutoNation makes big digital push.
BMW brings performance school online.
Simon Cowell proposes truce in competition between his X Factor on Fox and The Voice on NBC.
Fender tries to stay plugged in.
Ford hits the road to tout new C-Max nameplate.
GM recalls cars over fuel leak problem.Continue reading...
Posted by Shirley Brady on July 2, 2012 08:45 AM
Apple pays $60M to end iPad trademark dispute in China, looks to secure ipad3.com domain.
Barclays scandal forces out chairman, saying "the buck stops with me."
Bristol-Myers agrees to buy Amylin Pharmaceuticals for $5B in cash, expands diabetes alliance.
Rupert Murdoch will rebrand the Wall Street Journal as WSJ as part of News Corp. split.
AMC parent ends AT&T U-verse TV dispute with long-term agreement, as Dish feud continues.
Applebee's rolls out fresh menu, look and campaign.Continue reading...
Posted by Dale Buss on June 27, 2012 09:02 AM
AOL brings "project devil" ad format to mobile phones and tablets.
Apple's iPhone guides blind Olympic torch carrier.
AT&T still benefits from having been first with iPhone.
Apple gets major win in tablet wars after judge stops Samsung from selling Galaxy version in U.S.
Best Buy founder may try to take chain private.
Brut seeks "The Essence of Man" in digital campaign.
Campari eyes American women.Continue reading...
Posted by Dale Buss on June 19, 2012 09:01 AM
Microsoft unveils Surface tablet to take on iPad.
Walgreen is buying 45% stake in European pharmacy chain Boots for $6.7 billion.
Spotify rolls out free mobile radio for iPhone and iPad in U.S. to take on Pandora.
Caribou Coffee revels in being alternative to Starbucks.
Carrefour CEO offers turnaround plan.
Cisco expands use of WebEx brand.
Coca-Cola remains unbowed by New York Mayor Bloomberg's anti-soda campaign.Continue reading...
Posted by Dale Buss on June 11, 2012 09:01 AM
AOL faces crossroads with shareholders at annual meeting.
Airbus may take eight weeks for A380 wing fix.
Apple rumor mill churns ahead of WWDC announcements this week as it beats Google for loyalty of app developers.
BBC hires marketing chief from Diageo.
BMW and Audi post record sales as China boom continues.
CNN reportedly close to acquiring Mashable.
Domino's overseas business now beats U.S.
Facebook already appears past days of wild user growth.Continue reading...
Posted by Dale Buss on May 7, 2012 09:01 AM
ABC News and Univision team up to launch 24-hour English-language news channel for Hispanic viewers.
American Airlines seeks more overseas flights amid US Airways bid, Bloomberg says.
Amtrak enlists iPhone as service tool.
Apple may be ready to settle iPad China trademark dispute.
AT&T CEO regrets unlimited data iPhone plan.
Barclays enters U.S. banking fray with online service.
Budweiser sees boycott by NYT's Nick Kristof, while Bud Light tries to manage line extensions.
CBS steers younger viewers to 60 Minutes.
Chinese consumers are rejecting "Made in China."Continue reading...
Posted by Dale Buss on April 13, 2012 09:01 AM
AB InBev trying to make Budweiser the "Coke of beers."
Apple plays offense and defense in patent fights as it rejects e-book collusion charge.
Beef Products struggles to survive "pink slime" furor.
Best Buy probes ex-CEO relationship with female subordinate.
BrightSource Energy action highlights difficulties of solar market.
Carrefour lowers prices to aid sales.
Google preserves cash and control with two-for-one stock spit. Continue reading...
Posted by Barry Silverstein on February 22, 2012 01:25 PM
Battling counterfeit products is one of a brand's biggest headaches. More often than not, counterfeiting strikes luxury and accessory brands, since it is easier to sell fake branded handbags, shoes, and clothes online and in flea markets and bazaars around the world. But what about when buying a knock-off has life-or-death implications?
Fake products are penetrating an even more serious category than luxury goods — pharmaceuticals. America's Food and Drug Administration just announced the findings of the agency’s investigation of fake vials of the cancer drug Avastin that have showed up in California, Illionis, and Texas.
The FDA's tests indicated the vials did not contain Avastin's active ingredient, and traced the phony drug to the U.K. via a distributor in Tennessee. Reuters reported that the fake Avastin apparently originated in Cairo, Egypt and went from there through Switzerland to Britain. While the FDA was warned about the products by British officials late last year, it only confirmed that they were counterfeit last week. Cancer patients and medical practitioners, understandably, are up in arms.Continue reading...